Skip to main content
Clinical Trials/CTRI/2013/03/003474
CTRI/2013/03/003474
Completed
未知

Evaluation of dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types. - Nil

ITC R D Center0 sites24 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ITC R D Center
Enrollment
24
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ITC R D Center

Eligibility Criteria

Inclusion Criteria

  • Subject age group 18\-55 years.
  • \-Healthy Male and Female Volunteers.
  • \-Subject with skin type III and IV.
  • \-Subject willing to give a written Informed consent.
  • \-Subject willing to maintain the patch test in position for 24 hrs.
  • \-Subject has not participated in similar investigation in the past two weeks.
  • \-Subject willing to come for regular follow up.
  • \-Subject ready to follow instructions during the study period.

Exclusion Criteria

  • \-Infection, Allergy on tested area.
  • \-Skin allergy antecedents or atopic subjects.
  • \-Hyper sensitivity to any component of the tested products.
  • \-Athletes and subjects with history of excessive sweating.
  • \-Cutaneous disease which may influence the study result.
  • \-Chronic illness which may influence the cutaneous state.
  • \- Subjects on oral corticosteroid with dose 10mg/day.
  • \-Subjects participating in any other cosmetic or therapeutic trial.
  • \-Any history of underlying uncontrolled medical illness including diabetes, Liver disease or history of alcoholism, HIV or any other serious medical illness.

Outcomes

Primary Outcomes

Not specified

Similar Trials